Atrial secretion of B-type natriuretic peptide

European Heart Journal

Volumn 27, Issue 14, 2006, Pages 1648-1650

  Goetze, Jens Peter ^a   Friis Hansen, Lennart ^a   Rehfeld, Jens F ^a   Nilsson, Brian ^a   Svendsen, Jesper Hastrup ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

ANP; Atrial fibrillation; BNP; Heart failure; proANP; proBNP

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE;

BLOOD PRESSURE REGULATION; ENDOCRINE FUNCTION; GENE EXPRESSION REGULATION; HEART ATRIUM; HEART ATRIUM FIBRILLATION; HEART DISEASE; HEART FAILURE; HEART MUSCLE CELL; HEART VENTRICLE FUNCTION; HORMONE BLOOD LEVEL; HORMONE RELEASE; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; REVIEW;

ATRIAL FIBRILLATION; HEART ATRIA; HEART FAILURE; HEART FAILURE, CONGESTIVE; HUMANS; MICROSCOPY, CONFOCAL; MYOCYTES, CARDIAC; NATRIURETIC PEPTIDE, BRAIN;

EID: 33745777995     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehl109     Document Type: Review

References (22)

1. Mukoyama M, Nakao K, Hosoda K, Suga I, Saito Y, Ogawa Y, Shirakami G, Jougasaki M, Obata K, Yasure H, Kambayashi Y, Inouye K, Imura H. Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide J Clin Invest 1991;87:1402-1412.
2. Cowie MR, Jourdain P, Maisel A, Dahlstrom U, Follath F, Isnard R, Luchner A, McDonagh T, Mair J, Nieminen M, Francis G. Clinical applications of B-type natriuretic peptide (BNP) testing. Eur Heart J 2003;24:1710-1718.
3. de Lemos JA, McGuire DK, Drazner MH. B-type natriuretic peptide in cardiovascular disease. Lancet 2003;362:316-322.
4. de Bold AJ, Ma KK, Zhang Y, de Bold ML, Bensimon M, Khoshbaten A. The physiological and pathophysiological modulation of the endocrine function of the heart. Can J Physiol Pharmacol 2001;79:705-714.
5. Voulteenaho O, Ala-Kopsala M, Ruskoaho H. BNP as marker in heart disease. Adv Clin Chem 2005;40:1-36.
6. Ma KK, Ogawa T, de Bold AJ. Selective upregulation of cardiac brain natriuretic peptide at the transcriptional and translational levels by pro-inflammatory cytokines and by conditioned medium derived from mixed lymphocyte reactions via p38 MAP kinase. J Mol Cell Cardiol 2004;36:505-513.
7. Ellinor PT, Low AF, Patton KK, Shea MA, Macrae CA. Discordant atrial natriuretic peptide and brain natriuretic peptide levels in lone atrial fibrillation. J Am Coll Cardiol 2005;45:82-86.
8. Engelmann MD, Svendsen JH. Inflammation in the genesis and perpetuation of atrial fibrillation. Eur Heart J 2005;26:2083-2092.
9. Frustaci A, Chimenti C, Bellocci F, Morgante E, Russo MA, Masseri A. Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation 1997;96:1180-1184.
10. Nakamura Y, Nakamura K, Fukushima-Kusano K, Ohta K, Matsubara H, Hamuro T, Yutani C, Ohe T. Tissue factor expression in atrial endothelia associated with nonvalvular atrial fibrillation: possible involvement in intracardiac thrombogenesis. Thromb Res 2003;111:137-142.
11. Maixent JM, Paganelli F, Scaglione J, Levy S. Antibodies against myosin in sera of patients with idiopathic paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol 1998;9:612-617.
12. Gaudino M, Andreotti F, Zamparelli R, Di Castelnuovo A, Nasso G, Burzotta F, Iacoviello L Donati MB, Schiavello R, Masseri A, Possati G. The -174G/C Interleukin-6 polymorphism influences postoperative Interleukin-6 levels and postoperative atrial fibrillation. Is atrial fibrillation an inflammatory complication? Circulation 2003;108(Suppl. II):II-195-II-199.
13. Yared J-P, Starr NJ, Torres FK, Bashour CA, Bourdakos G, Piedmonte M, Michener JA, Davis JA, Rosenberger TE. Effects of single dose, postinduction dexamethasone on recovery after cardiac surgery. Ann Thorac Surg 2000;69:1420-1424.
14. Dernellis J, Panaretou M. Relationship between C-reactive protein concentrations during glucocorticoid therapy and recurrent atrial fibrillation. Eur Heart J 2004;25:1100-1107.
15. Knudsen CW, Omland T, Westheim A, Wu AH, McCord J, Nowak RM, Hollander JE, Storrow AB, Abraham WT, McCullough PA, Maisel A. Impact of atrial fibrillation on the diagnostic performance of B-type natriuretic peptide concentration in dyspneic patients: an analysis from the breathing not properly multinational study. J Am Coll Cardiol 2005;46:838-844.
16. Wozakowska-Kapton B. Effect of rhythm restoration on plasma brain natriuretic peptide in patients with atrial fibrillation. Am J Cardiol 2004;93:1555-1558.
17. Inoue S, Murakami Y, Sano K, Katoh H, Shimada T. Atrium as a source of brain natriuretic polypeptide in patients with atrial fibrillation. J Card Fail 2000;6:92-96.
18. Goetze JP. Biochemistry of pro-B-type natriuretic peptide-derived peptides: the endocrine heart revisited. Clin Chem 2004;50:1503-1510.
19. Bloch KD, Seidman JG, Naftilan LD, Seidman CE. Neonatal atria and ventricles secrete atrial natriuretic factor via tissue-specific secretory pathways. Cell 1983;47:695-702.
20. Christoffersen C, Goetze JP, Bartels ED, Larsen MO, Ribel U, Rehfeld JF, Rolin B, Nielsen LB. Chamber-dependent expression of brain natriuretic peptide and its mRNA in normal and diabetic pig heart. Hypertension 2002;40:54-60.
21. Giuliani I, Rieunier F, Larue C, Delagneau JF, Grainer C, Pau B, Ferriere M, Saussine M, Cristol JP, Dupuy AM, Merigeon E, Merle D, Villard S. Assay for measurement of intact B-type natriuretic peptide prohormone in blood. Clin Chem 2006. Published online ahead of print.
22. Prestle J, Dieterich S, Preuss M, Bieligk U, Hasenfuss G. Heterogeneous transmural gene expression of calcium-handling proteins and natriuretic peptides in the failing human heart. Cardiovasc Res 1999;43:323-331.